Watson resolves Opana ER patent dispute with Endo Pharma
Endo Pharma has filed lawsuit on 4 March 2010, following Watson’s filing of an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) for
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
The award is expected to fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen’s tetravalent dengue vaccine, DENVax delivered with PharmaJet’s convenient needle-free injection device. Inviragen